DAFTAR PUSTAKA
Agampodi, S.B., Matthias, M.A., Moreno, A.C., dan Vinetz, J.M., 2012. Utility of Quantitative Polymerase Chain Reaction in Leptospirosis Diagnosis:
Association of Level of Leptospiremia and Clinical Manifestations in Sri Lanka. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 54: 1249–1255.
Alian, S., Davoudi, A., Najafi, N., Ghasemian, R., Ahangarkani, F., dan Hamdi, Z., 2015. Clinical and laboratory manifestation and outcome of icterohemorrhagic leptospirosis patients in Northern Iran. Medical journal of the Islamic Republic of Iran, 29: 308.
Alwi, I., Salim, S., Hidayat, R., Kurniawan, J., dan Tahapary, D.L., 2016.
Penatalaksanaan Di Bidang Ilmu Penyakit Dalam Panduan Praktik Klinis. Interna Publishing.
Amilasan, A.T., Ujiie, M., Suzuki, M., Salva, E., Belo, M.C.P., Koizumi, N., dkk., 2012. Outbreak of Leptospirosis after Flood, the Philippines, 2009.
Emerging Infectious Diseases, 18: 91–94.
Andes, D., Anon, J., Jacobs, M.R., dan Craig, W.A., 2004. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections. Clinics in Laboratory Medicine, 24: 477–502.
Andrade, L., Cleto, S., dan Seguro, A.C., 2007. Door-to-Dialysis Time and Daily Hemodialysis in Patients with Leptospirosis: Impact on Mortality. Clinical Journal of the American Society of Nephrology, 2: 739–744.
Anonim, 2012, 'PK/PD Approach to Antibiotic Therapy Review', tersedia online di http://www.rxkinetics.com/antibiotic_pk_pd.html, diakses pada tanggal 4/12/2016.
Bandara, K., Weerasekera, M.M., Gunasekara, C., Ranasinghe, N., Marasinghe, C., dan Fernando, N., 2016. Utility of modified Faine‟s criteria in diagnosis of leptospirosis. BioMed Central Infectious Diseases, 16: . Brett-Major, D.M. dan Coldren, R., 2012. Antibiotics for leptospirosis, dalam:
Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd.
CDC, 2015, Leptospirosis, Altanta, Centers for Disease Control and Prevention.
Cerqueira, T.B., Athanazio, D.A., Spichler, A.S., dan Seguro, A.C., 2008. Renal involvement in leptospirosis--new insights into pathophysiology and treatment. The Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases, 12: 248–252.
Charan, J., Saxena, D., Mulla, S., dan Yadav, P., 2013. Antibiotics for the Treatment of Leptospirosis: Systematic Review and Meta-Analysis of Controlled Trials. International Journal of Preventive Medicine, 4: 501–
510.
Corwin, A., Ryan, A., Bloys, W., Thomas, R., Deniega, B., dan Watts, D., 1990.
A Waterborne Outbreak of Leptospirosis among United States Military Personnel in Okinawa, Japan. International Journal of Epidemiology, 19:
743–748.
Cosson, J.-F., Picardeau, M., Mielcarek, M., Tatard, C., Chaval, Y., Suputtamongkol, Y., dkk., 2014. Epidemiology of Leptospira Transmitted by Rodents in Southeast Asia. PLOS Neglected Tropical Diseases, 8: 1-10 Costa, F., Hagan, J.E., Calcagno, J., Kane, M., Torgerson, P., Martinez-Silveira, M.S., dkk., 2015. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLOS Neglected Tropical Diseases, 9: 1-16.
Costa, F., Martinez-Silveira, M.S., Hagan, J.E., Hartskeerl, R.A., Dos Reis, M.G., dan Ko, A.I., 2012. Surveillance for leptospirosis in the Americas, 1996- 2005: a review of data from ministries of health. Revista Panamericana De Salud Publica = Pan American Journal of Public Health, 32: 169–177.
Daher, E.D.F., Abreu, K.L.S. de, Junior, S., dan Da, G.B., 2010. Leptospirosis- associated acute kidney injury. Jornal Brasileiro de Nefrologia, 32: 408–
415.
Daher, E.D.F. dan Nogueira, C.B., 2000. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Revista do Instituto de Medicina Tropical de São Paulo, 42: 327–332.
Departemen Kesehatan RI, 2003, Pedoman Tatalaksana Kasus dan Pemeriksaan Laboratorium Leptospirosis di Rumah Sakit, Jakarta, Direktorat Jenderal Pemberantasan Penyakit Menular dan Penyehatan Lingkungan.
Dinas Kesehatan Propinsi D.I Yogyakarta, 2011, Profil Kesehatan Propinsi D.I Yogyakarta Tahun 2011, Dinas Kesehatan Propinsi D.I. Yogyakarta, Yogyakarta.
Directorate General of Health Service, 2015. 'National Guidelines Diagnosis, Case Management Prevention and Control of Leptospirosis', National Centre For Disease Control, Delhi.
Fatmasari, H., Caecilia, M., dan Herlyanti, K., 2015. 'Evaluasi Penggunaan Antibiotik Pada Pasien Leptospirosis Di Instalasi Rawat Inap RSUD Kota Semarang Periode Januari 2010 - Desember 2013', , Skripsi, . Sekolah Tinggi Ilmu Farmasi “Yayasan Pharmasi,” Semarang.
Faucher, J.-F., Chirouze, C., Hoen, B., Leroy, J., Hustache-Mathieu, L., dan Estavoyer, J.-M., 2015. Short-course treatment with ceftriaxone for leptospirosis: A retrospective study in a single center in Eastern France.
Journal of Infection and Chemotherapy, 21: 227–228.
FDA, 2016, Drug Development Tools Qualification Programs – Clinical Outcome Assessment Qualification Program, tersedia online di http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugDevelopme ntToolsualificationProgram/ucm284077.htm, diakses pada tanggal 23/8/2016).
Forbes, A.E., Zochowski, W.J., Dubrey, S.W., dan Sivaprakasam, V., 2012.
Leptospirosis and Weil‟s disease in the UK. Quarterly Journal of Medicine, 105: 1151–1162.
Gompf, S.G., 2016, 'Leptospirosis: Practice Essentials, Background, Pathophysiology', Medscape, tersedia online di http://www.emedicine.medscape.com/article/220563-overview#a6, diakses pada 7/11/2016.
Haake, D.A. dan Levett, P.N., 2015. Leptospirosis in Humans. Current topics in microbiology and immunology, 387: 65–97.
Hakim, L., 2015. Farmakokinetik Klinik. Bursa Ilmu, Yogyakarta.
Hartskeerl, R.A. dan Wagenaar, J.F.P., 2015. Leptospirosis, dalam: Kasper, D.L., Hauser, S.L., Jameson, J.L., Fauci, A.S., Longo, D.L., dan Loscalzo, J.
(Editor), Harrison’s Principles of Internal Medicine. McGraw-Hill Education / Medical, New York, hal. 1140–1145.
Kamath, R., Swain, S., Pattanshetty, S., dan Nair, N.S., 2014. Studying Risk Factors Associated with Human Leptospirosis. Journal of Global Infectious Diseases, 6: 3–9.
Kasamira, C.., 2016. 'Evaluasi Peresepan Antibiotika Dengan Metode Gyssens Pada Pasien Leptospirosis di RSUD Panembahan Senopati Bantul Periode Januari - Mei 2015', , Skripsi, . Universitas Sanata Dharma, Yogyakarta.
Kasper, D.L., Fauci, A.S., Hauser, S., Longo, D., Jameson, J.L., dan Loscalzo, J., 2015. Harrison’s Principles of Internal Medicine, 19 edition. ed.
McGraw-Hill Education / Medical, New York.
Katz, A.R., Ansdell, V.E., Effler, P.V., Middleton, C.R., dan Sasaki, D.M., 2001.
Assessment of the Clinical Presentation and Treatment of 353 Cases of Laboratory-Confirmed Leptospirosis in Hawaii, 1974–1998. Clinical Infectious Diseases, 33: 1834–1841.
Kellum, J.A., Lameire, N., Aspelin, P., Barsoum, R.S., Burdmann, E.A., Goldstein, S.L., dkk., 2012. Work group membership. Kidney International, 2: 1-141.
Kementerian Kesehatan RI, 2011, Pedoman Pelayanan Kefarmasian untuk Terapi Antibiotik, Kementerian Kesehatan Republik Indonesia, Jakarta.
Kementerian Kesehatan RI, 2015, Peraturan Menteri Kesehatan Republik Indonesia No. 8 Tahun 2015 tentang Program Pengendalian Resistensi Antibiotik, Kementerian Kesehatan Republik Indonesia, Jakarta.
Kementerian Kesehatan RI, 2016, Profil Kesehatan Indonesia Tahun 2015, Kementerian Kesehatan Republik Indonesia, Jakarta.
Kobayashi, Y., 2005. Human leptospirosis: management and prognosis. Journal of Postgraduate Medicine, 51: 201–204.
Lacy, C.F., Amstrong, L.L., Goldman, M.P., Lance, L.L. (ed). 2011, Drug Information Handbook with Internastional Trade Names Index, 20th edition, Lexi-com Inc., Ohio. US.
Lingappa, J., Kuffner, T., Tappero, J., Whitworth, W., Mize, A., Kaiser, R., dkk., 2004. HLA-DQ6 and ingestion of contaminated water: possible gene- environment interaction in an outbreak of Leptospirosis. Genes and Immunity, 5: 197–202.
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., dkk., 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380: 2095–2128.
Mudur, G., 2005. Mumbai braces itself for leptospirosis and waterborne infections. British Medical Journal, 331: 307.
Murray, C.K. dan Hospenthal, D.R., 2004. Determination of Susceptibilities of 26 Leptospira sp. Serovars to 24 Antimicrobial Agents by a Broth Microdilution Technique. Antimicrobial Agents and Chemotherapy, 48:
4002–4005.
Niwattayakul, K. dan Sitprija, V., 2007. Leptospiral Acute Renal Failure: Effects of Dopamine and Furosemide. Renal Failure, 29: 159–162.
Nurbeti, M., Kusnanto, H., dan Nugroho, W.S., 2016. Kasus - kasus leptospirosis di perbatasan Kabupaten Bantul, Sleman, dan Kulon Progo: Analisis spasial. Kesmas: National Public Health Journal, 7: 1–14.
Nurmilawati, N., 2005. 'Faktor - Faktor Risiko Kematian pada Kematian pada Penderita Leptospirosis Berat Di Rumah Sakit Se-kota Semarang', , masters, . Program Pasca Sarjana Universitas Diponegoro.
Panaphut, T., Domrongkitchaiporn, S., Vibhagool, A., Thinkamrop, B., dan Susaengrat, W., 2003. Ceftriaxone Compared with Sodium Penicillin G for Treatment of Severe Leptospirosis. Clinical Infectious Diseases, 36:
1507–1513.
Phimda, K., Hoontrakul, S., Suttinont, C., Chareonwat, S., Losuwanaluk, K., Chueasuwanchai, S., dkk., 2007. Doxycycline versus Azithromycin for Treatment of Leptospirosis and Scrub Typhus. Antimicrobial Agents and Chemotherapy, 51: 3259–3263.
Picardeau, M., 2013. Diagnosis and epidemiology of leptospirosis. Médecine et Maladies Infectieuses, 43: 1–9.
Punjabi, N.H., Taylor, W.R.J., Murphy, G.S., Purwaningsih, S., Picarima, H., Sisson, J., dkk., 2012. Etiology of Acute, Non-Malaria, Febrile Illnesses in Jayapura, Northeastern Papua, Indonesia. The American Journal of Tropical Medicine and Hygiene, 86: 46–51.
Ramadhani, T. dan Yunianto, B., 2012. Reservoir dan kasus leptospirosis di wilayah kejadian luar biasa. Kesmas: National Public Health Journal, 7:
162–168.
Reis, E.A.G., Hagan, J.E., Ribeiro, G.S., Teixeira-Carvalho, A., Martins-Filho, O.A., Montgomery, R.R., dkk., 2013. Cytokine response signatures in disease progression and development of severe clinical outcomes for leptospirosis. PLoS neglected tropical diseases, 7: e2457.
Ressner, R.A., Griffith, M.E., Beckius, M.L., Pimentel, G., Miller, R.S., Mende, K., dkk., 2008. Antimicrobial Susceptibilities of Geographically Diverse Clinical Human Isolates of Leptospira. Antimicrobial Agents and Chemotherapy, 52: 2750–2754.
Schreier, S., Doungchawee, G., Triampo, D., Wangroongsarb, P., Hartskeerl, R.A., dan Triampo, W., 2012. Development of a magnetic bead fluorescence microscopy immunoassay to detect and quantify Leptospira in environmental water samples. Acta Tropica, 122: 119–125.
Schulz, M. dan Schmoldt, A., 2003. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Die Pharmazie-An International Journal of Pharmaceutical Sciences, 58: 447–474.
Segura, E.R., Ganoza, C.A., Campos, K., Ricaldi, J.N., Torres, S., Silva, H., dkk., 2005. Clinical Spectrum of Pulmonary Involvement in Leptospirosis in a
Region of Endemicity, with Quantification of Leptospiral Burden. Clinical Infectious Diseases, 40: 343–351.
Sethi, S., Sharma, N., Kakkar, N., Taneja, J., Chatterjee, S.S., Banga, S.S., dkk., 2010. Increasing Trends of Leptospirosis in Northern India: A Clinico- Epidemiological Study. PLOS Neglected Tropical Diseases, 4: 1-7.
Shargel, L. dan Yu, A.B.C., 2005. Biofarmasetika Dan Farmakokinetika Terapan, 2nd ed. Airlangga University Press, Surabaya.
Smythe, L., Adler, B., Hartskeerl, R.A., Galloway, R.L., Turenne, C.Y., Levett, P.N., dkk., 2013. Classification of Leptospira genomospecies 1, 3, 4 and 5 as Leptospira alstonii sp. nov., Leptospira vanthielii sp. nov., Leptospira terpstrae sp. nov. and Leptospira yanagawae sp. nov., respectively.
International Journal of Systematic and Evolutionary Microbiology, 63:
1859–1862.
Stern, E.J., Galloway, R., Shadomy, S.V., Wannemuehler, K., Atrubin, D., Blackmore, C., dkk., 2010. Outbreak of Leptospirosis among Adventure Race Participants in Florida, 2005. Clinical Infectious Diseases, 50: 843–
849.
Suputtamongkol, Y., Niwattayakul, K., Suttinont, C., Losuwanaluk, K., Limpaiboon, R., Chierakul, W., dkk., 2004. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clinical Infectious Diseases, 39: 1417–1424.
Terpstra, W.J., World Health Organization, dan International Leptospirosis Society (Editor), 2003. Human Leptospirosis: Guidance for Diagnosis, Surveillance and Control. World Health Organization, Geneva.
Truccolo, J., Charavay, F., Merien, F., dan Perolat, P., 2002. Quantitative PCR Assay To Evaluate Ampicillin, Ofloxacin, and Doxycycline for Treatment of Experimental Leptospirosis. Antimicrobial Agents and Chemotherapy, 46: 848–853.
WHO, 2003, Human Leptospirosis : Guidance for Diagnosis, Surveilance and Control, Geneva, World Health Organization.
WHO, 2016, Leptospirosis, Geneva, World Health Organization.
Wiwanitkit, V., 2006, Comparison Between Blood Exchange and Classical Therapy for Acute Renal Failure in Weil‟s Disease: Appraisal on Thai Reports, Nephrology, 11(5):480-481.
